Sort   by:  
 Page size 
UnknownNovel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting.
Not available
S-EPMC7589658 | biostudies-literature
UnknownSorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO).
Not available
S-EPMC4576908 | biostudies-literature
UnknownRegorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.
Not available
S-EPMC10265601 | biostudies-literature
UnknownOutcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study.
Not available
S-EPMC6089183 | biostudies-literature
UnknownRetroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
Not available
S-EPMC4433510 | biostudies-literature
UnknownHypomethylation of the MEG8:Int2-DMR in patients with pathogenic PLAG1 variants suggests new role of the chr14q32 imprinting cluster in Silver-Russell syndrome.
Not available
S-EPMC12764072 | biostudies-literature
UnknownCabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Not available
S-EPMC8763616 | biostudies-literature
UnknownClinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registry
Not available
S-EPMC12336835 | biostudies-literature
UnknownLong term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma.
Not available
S-EPMC10774964 | biostudies-literature
UnknownThe current landscape of European registries for rare endocrine conditions.
Not available
S-EPMC6347278 | biostudies-literature
Sort   by:  
 Page size